The injection against SARS-CoV-2 failed the quality control
Workers at a factory in New York-Baltimore accidentally manufactured two coronavirus vaccines a few weeks ago, mixing the vaccine ingredients together, ruining about 15 million doses of Johnson & Johnson vaccine, and forcing regulators to crack down and delay the factory’s production line Approved.
The plant is operated by Emergent BioSolutions, a production partner of Johnson & Johnson and AstraZeneca. Federal officials attributed the failure to human error.
During the US Food and Drug Administration’s investigation, this confusion has prevented Johnson & Johnson from shipping future doses in the United States. The company has taken measures to strengthen the control of Emergent BioSolutions’ work to avoid further quality issues.
This one-dose vaccine is believed to boost the national immunization program.
This error will not affect the Johnson & Johnson dose currently used and used nationwide. All these doses are produced in the Netherlands, and their operations have been fully approved by federal regulatory agencies.
But all subsequent shipments of Johnson & Johnson vaccine, which are expected to total tens of millions of doses next month, should come from the huge Baltimore plant.
People familiar with the matter said that these goods are now being resolved when there is a problem with quality control issues.
Federal officials still hope that there will be enough doses to fulfill President Biden’s promise to provide enough vaccines to immunize all adults by the end of May.
Two other federally licensed manufacturers, including Pfizer-BioNTech and Moderna, will still deliver as expected.
Pfizer will deliver the dose ahead of schedule, and Moderna will receive approval to provide up to 15 doses instead of 10 doses of packaged vaccine vials, which will further increase the country’s inventory.
According to data from the Centers for Disease Control and Prevention (CDC), Johnson & Johnson has delivered approximately 6.8 million doses as of Wednesday. Some additional doses may not have been recorded until the delivery time. The CDC said on Wednesday that starting today, another 11 million doses of vaccine will be available for distribution.